Cargando…
Where are we now? Emerging opportunities and challenges in the management of secondary hyperparathyroidism in patients with non-dialysis chronic kidney disease
ABSTRACT: Rising levels of parathyroid hormone (PTH) are common in patients with chronic kidney disease (CKD) not on dialysis and are associated with an elevated risk of morbidity (including progression to dialysis) and mortality. However, there are several challenges for the clinical management of...
Autores principales: | Ketteler, Markus, Ambühl, Patrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494658/ https://www.ncbi.nlm.nih.gov/pubmed/34170509 http://dx.doi.org/10.1007/s40620-021-01082-2 |
Ejemplares similares
-
Treatment of secondary hyperparathyroidism in non-dialysis CKD: an appraisal 2022s
por: Ketteler, Markus, et al.
Publicado: (2022) -
Vitamin D and Secondary Hyperparathyroidism in Chronic Kidney Disease: A Critical Appraisal of the Past, Present, and the Future
por: Brandenburg, Vincent, et al.
Publicado: (2022) -
Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023) -
Where are we now?
Publicado: (1977) -
Extension for Community Healthcare Outcomes (ECHO) Telementoring in the Military: Where We Are Now, Opportunities and Challenges
por: Katzman, Joanna, et al.
Publicado: (2021)